Trump’s aides are discussing making the Treasury chief the top White House economic advisor, in addition to his current job, plus acting IRS commissioner.
The partnership will focus on Crescent’s PD-1/VEGF inhibitor CR-001 and Kelun-Biotech’s SKB105, both of which the companies plan to push into Phase I/II development for solid tumors early next year.
The House approved two pieces of legislation to keep IRS agents from levying fines and penalties without supervisory approval, and to strengthen taxpayer rights in proceedings before the Tax Court.
The word “transformation” doesn’t do justice to the kinds of seismic changes that have started to take root in the accounting profession over the past year.